ECONAZOLE NITRATE

Post-LOE

econazole nitrate

PharmaIN

ANDATOPICALCREAM

Approved

Nov 2002

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

4/8 — Partial

ECONAZOLE NITRATE (econazole nitrate) by PharmaIN is clinical pharmacology after topical application to the skin of normal subjects, systemic absorption of econazole nitrate is extremely low. Approved for interdigital tinea pedis caused by trichophyton rubrum, trichophyton mentagrophytes, epidermophyton floccosum in patients 12 years of age and 1 more indications. First approved in 2002.

Drug data last refreshed 20h ago

$0.0BPart D

Mechanism of Action

CLINICAL PHARMACOLOGY After topical application to the skin of normal subjects, systemic absorption of econazole nitrate is extremely low. Although most of the applied drug remains on the skin surface, drug concentrations were found in the stratum corneum, which, by far, exceeded the minimum…

Indications (4)

interdigital tinea pedis caused by Trichophyton rubrum

Worked on ECONAZOLE NITRATE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.